GoodRx Holdings, Inc. (GDRX) Research
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Market snapshot
- Symbol
- GDRX
- Price
- $2.66
- Day change
- +1.92%
- Market cap
- $922.0M
- P/E ratio
- 44.07x
- 52-week range
- 1.77-5.81
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Next earnings
- in 2 months
- Analyst price target
- $3.08
Recent news
- GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
• GoodRx Holdings shares are advancing steadily. What's driving GDRX shares up?
Peer companies
Recent insider activity
- REY-GIRAUD AGNES — A-Award (73434 shares) on 2026-06-16
- Kennedy Kelly J. — A-Award (73434 shares) on 2026-06-16
- Hirsch Douglas Joseph — A-Award (73434 shares) on 2026-06-16
- Bruehlman Ronald E — A-Award (73434 shares) on 2026-06-16
- Bezdek Trevor — A-Award (73434 shares) on 2026-06-16
Open GoodRx Holdings, Inc. (GDRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.